NICE Clinical Guideline 93

Donor breast milk banks: the operation of donor milk bank services

The recommendations from NICE cover:
  • Screening and selecting donors, including:
    • serological testing
    • consent and continued eligibility
  • Training and supporting donors
  • Handling donor milk:
    • at home
    • during transportation
    • at the milk bank
  • Tracking and tracing donor milk

Web address: www.nice.org.uk/guidance/CG93

NICE Technology Appraisal 185

Trabectedin for the treatment of advanced soft tissue sarcoma

Summary
  • Trabectedin is recommended as a possible treatment for people with advanced soft tissue sarcoma if:
    • treatment with anthracyclines and ifosfamide has failed or
    • anthracyclines and ifosfamide cannot be tolerated by the patient or
    • anthracyclines and ifosfamide are unsuitable
  • Under a ‘patient access scheme’, the manufacturer has agreed to provide the NHS with further trabectedin treatment free of charge for any patient requiring more than five treatments.

Web address: www.nice.org.uk/guidance/TA185

NICE Technology Appraisal 186

Certolizumab pegol for the treatment of rheumatoid arthritis

Summary
  • Certolizumab pegol is recommended as a possible treatment for people with rheumatoid arthritis who:
    • have already tried methotrexate and another disease-modifying anti-rheumatic drug, for trial periods of at least 6 months and
    • have severe ‘active’ rheumatoid arthritis, as assessed by a rheumatologist on two separate occasions
  • Treatment should only be continued if the rheumatoid arthritis has improved sufficiently after 6 months, and patient check ups should take place every 6 months to make sure the disease is still responding to the drug.

Web address: www.nice.org.uk/guidance/TA186